Superoxide and Derived Reactive Oxygen Species in the Regulation of Hypoxia-Inducible Factors

Methods in Enzymology

Volumn 435, Issue , 2007, Pages 421-446

  Görlach, Agnes ^a   Kietzmann, Thomas ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; DIHYDRORHODAMINE 123; FLUORESCENT DYE; HYDROETHIDINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATASE; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; HYPOXIA INDUCIBLE FACTOR 1;

CELL ACTIVATION; CELL TYPE; CELLULAR STRESS RESPONSE; CHEMOLUMINESCENCE; ELECTRON SPIN RESONANCE; FLUORESCENCE; HYPOXIA; PRIORITY JOURNAL; PROTEIN DEGRADATION; REDUCTION KINETICS; REGULATORY MECHANISM; REVIEW; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; CHEMILUMINESCENT MEASUREMENTS; CYTOCHROMES C; ELECTRON SPIN RESONANCE SPECTROSCOPY; FLUORESCENT DYES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 39749136529     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)35022-2     Document Type: Review

References (133)

1. Babior B.M. NADPH oxidase. Curr. Opin. Immunol. 16 (2004) 42-47
2. Beck I., Weinmann R., and Caro J. Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82 (1993) 704-711
3. BelAiba R.S., Djordjevic T., Bonello S., Flugel D., Hess J., Kietzmann T., and Görlach A. Redox-sensitive regulation of the HIF pathway under non-hypoxic conditions in pulmonary artery smooth muscle cells. Biol. Chem. 385 (2004) 249-257
4. BelAiba R.S., Djordjevic T., Petry A., Diemer K., Bonello S., Hess J., Pogrebniak A., Bickel C., and Görlach A. NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 42 (2007) 446-459
5. Benov L., Sztejnberg L., and Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radic. Biol. Med. 25 (1998) 826-831
6. Block K., Gorin Y., Hoover P., Williams P., Chelmicki T., Clark R.A., Yoneda T., and Abboud H.E. NAD(P)H oxidases regulate HIF-2α protein expression. J. Biol. Chem. 282 (2007) 8019-8026
7. Blouin C.C., Page E.L., Soucy G.M., and Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: Implication of hypoxia-inducible factor 1alpha. Blood 103 (2004) 1124-1130
8. Bokoch G.M., and Knaus U.G. NADPH oxidases: Not just for leukocytes anymore!. Trends Biochem. Sci. 28 (2003) 502-508
9. Bonello S., Zähringer C., BelAiba R.S., Djordjevic T., Hess J., Michiels C., Kietzmann T., and Görlach A. Reactive oxygen species activate the HIF-1α promoter via a functional NF-κB site. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 755-761
10. Brigelius-Flohe R., Banning A., and Schnurr K. Selenium-dependent enzymes in endothelial cell function. Antioxid. Redox. Signal. 5 (2003) 205-215
11. Budd S.L., Castilho R.F., and Nicholls D.G. Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett. 415 (1997) 21-24
12. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 87 (2000) 840-844
13. Carrero P., Okamoto K., Coumailleau P., O'Brien S., Tanaka H., and Poellinger L. Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol. Cell Biol. 20 (2000) 402-415
14. 2 sensing. J. Biol. Chem. 275 (2000) 25130-25138
15. Chiarugi P. PTPs versus PTKs: The redox side of the coin. Free Radic.Res. 39 (2005) 353-364
16. Dikalov S.I., Li W., Mehranpour P., Wang S.S., and Zafari A.M. Production of extracellular superoxide by human lymphoblast cell lines: Comparison of electron spin resonance techniques and cytochrome C reduction assay. Biochem. Pharmacol. 73 (2006) 972-980
17. Djordjevic T., Pogrebniak A., BelAiba R.S., Bonello S., Wotzlaw C., Acker H., Hess J., and Görlach A. The expression of the NADPH oxidase subunit p22phox is regulated by a redox-sensitive pathway in endothelial cells. Free Radic. Biol. Med. 38 (2005) 616-630
18. Duyndam M.C., Hulscher T.M., Fontijn D., Pinedo H.M., and Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J. Biol. Chem. 276 (2001) 48066-48076
19. Ema M., Hirota K., Mimura J., Abe H., Yodoi J., Sogawa K., Poellinger L., and Fujii-Kuriyama Y. Molecular mechanisms of transcription activation by HLF and HIF-1α in response to hypoxia: Their stabilization and redox signal-induced interaction with CBP/p300. EMBO J. 18 (1999) 1905-1914
20. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
21. Finkel T. Reactive oxygen species and signal transduction. IUBMB Life 52 (2001) 3-6
22. Frede S., Stockmann C., Freitag P., and Fandrey J. Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB. Biochem. J. 396 (2006) 517-527
23. Freeman B.A., and Crapo J.D. Free-radicals and tissue-injury. Lab. Invest. 47 (1982) 412-426
24. Frejaville C., Karoui H., Tuccio B., Le Moigne F., Culcasi M., Pietri S., Lauricella R., and Tordo P. 5-(Diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide: A new efficient phosphorylated nitrone for the in vitro and in vivo spin trapping of oxygen-centered radicals. J. Med. Chem. 38 (1995) 258-265
25. Fukuda R., Kelly B., and Semenza G.L. Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1. Cancer Res. 63 (2003) 2330-2334
26. Fukuda R., Hirota K., Fan F., Jung Y.D., Ellis L.M., and Semenza G.L. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277 (2002) 38205-38211
27. Furst R., Brueckl C., Kuebler W.M., Zahler S., Krotz F., Görlach A., Vollmar A.M., and Kiemer A.K. Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase/Nox2-activation. Circ. Res. 96 (2005) 43-53
28. Gao N., Shen L., Zhang Z., Leonard S.S., He H., Zhang X.G., Shi X., and Jiang B.H. Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell Biochem. 255 (2004) 33-45
29. Gao N., Ding M., Zheng J.Z., Zhang Z., Leonard S.S., Liu K.J., Shi X., and Jiang B.H. Vanadate-induced expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277 (2002) 31963-31971
30. Gao N., Jiang B.H., Leonard S.S., Corum L., Zhang Z., Roberts J.R., Antonini J., Zheng J.Z., Flynn D.C., Castranova V., and Shi X. p38 signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 277 (2002) 45041-45048
31. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., Pouyssegur J., Yaniv M., and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (2004) 781-794
32. Görlach A., Kietzmann T., and Hess J. Redox signaling through NADPH oxidases: Involvement in vascular proliferation and coagulation. Ann. N.Y. Acad. Sci. 973 (2002) 505-507
33. Görlach A., Camenisch G., Kvietikova I., Vogt L., Wenger R.H., and Gassmann M. Efficient translation of mouse hypoxia-inducible factor-1alpha under normoxic and hypoxic conditions. Biochim. Biophys. Acta 1493 (2000) 125-134
34. Görlach A., Holtermann G., Jelkmann W., Hancock J.T., Jones S.A., Jones O.T., and Acker H. Photometric characteristics of haem proteins in erythropoietin-producing hepatoma cells (HepG2). Biochem. J. 290 (1993) 771-776
35. Görlach A., Diebold I., Schini-Kerth V.B., Berchner-Pfannschmidt U., Roth U., Brandes R.P., Kietzmann T., and Busse R. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89 (2001) 47-54
36. Griendling K.K. Novel NAD(P)H oxidases in the cardiovascular system. Heart 90 (2004) 491-493
37. Groemping Y., and Rittinger K. Activation and assembly of the NADPH oxidase: A structural perspective. Biochem. J. 386 (2004) 401-416
38. Gross J., Rheinlander C., Fuchs J., Mazurek B., Machulik A., Andreeva N., and Kietzmann T. Expression of hypoxia-inducible factor 1 in the cochlea of newborn rats. Heart Res. 183 (2003) 73-83
39. Haddad J.J., Olver R.E., and Land S.C. Antioxidant/pro-oxidant equilibrium regulates HIF-1α and NF-κB redox sensitivity. Evidence for inhibition by glutathione oxidation in alveolar epithelial cells. J. Biol. Chem. 275 (2000) 21130-21139
40. Hara S., Hamada J., Kobayashi C., Kondo Y., and Imura N. Expression and characterization of hypoxia-inducible factor (HIF)-3alpha in human kidney: Suppression of HIF-mediated gene expression by HIF-3α. Biochem. Biophys. Res. Commun. 287 (2001) 808-813
41. Heidbreder M., Frohlich F., Johren O., Dendorfer A., Qadri F., and Dominiak P. Hypoxia rapidly activates HIF-3α mRNA expression. FASEB J. 17 (2003) 1541-1543
42. Henderson L.M., and Chappell J.B. Dihydrorhodamine 123: A fluorescent probe for superoxide generation?. Eur. J. Biochem. 217 (1993) 973-980
43. Herkert O., Djordjevic T., BelAiba R.S., and Görlach A. Insights into the redox control of blood coagulation: Role of vascular NADPH oxidase-derived reactive oxygen species in the thrombogenic cycle. Antioxid. Redox. Signal. 6 (2004) 765-776
44. Hewitson K.S., McNeill L.A., Riordan M.V., Tian Y.M., Bullock A.N., Welford R.W., Elkins J.M., Oldham N.J., Bhattacharya S., Gleadle J.M., Ratcliffe P.J., Pugh C.W., et al. Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277 (2002) 26351-26355
45. Hirota K., Fukuda R., Takabuchi S., Kizaka-Kondoh S., Adachi T., Fukuda K., and Semenza G.L. Induction of hypoxia-inducible factor 1 activity by muscarinic acetylcholine receptor signaling. J. Biol. Chem. 279 (2004) 41521-41528
46. Hoffman E.C., Reyes H., Chu F.F., Sander F., Conley L.H., Brooks B.A., and Hankinson O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252 (1991) 954-958
47. Hu C.J., Wang L.Y., Chodosh L.A., Keith B., and Simon M.C. Differential roles of hypoxia-inducible factor 1alpha (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell Biol. 23 (2003) 9361-9374
48. Huang L.E., Arany Z., Livingston D.M., and Bunn H.F. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271 (1996) 32253-32259
49. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
50. 2 sensing. Science 292 (2001) 464-468
51. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., and Kaelin Jr. W.G. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99 (2002) 13459-13464
52. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
53. Jiang B.H., Zheng J.Z., Leung S.W., Roe R., and Semenza G.L. Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272 (1997) 19253-19260
54. Johnston Jr. R.B., Godzik C.A., and Cohn Z.A. Increased superoxide anion production by immunologically activated and chemically elicited macrophages. J. Exp. Med. 148 (1978) 115-127
55. Kaelin Jr. W.G., and Maher E.R. The VHL tumour-suppressor gene paradigm. Trends Genet. 14 (1998) 423-426
56. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway. J. Biol. Chem. 274 (1999) 6519-6525
57. Kamura T., Sato S., Haque D., Liu L., Kaelin-WG J., Conaway R.C., and Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12 (1998) 3872-3881
58. Khatri J.J., Johnson C., Magid R., Lessner S.M., Laude K.M., Dikalov S.I., Harrison D.G., Sung H.J., Rong Y., and Galis Z.S. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109 (2004) 520-525
59. Khomenko T., Deng X., Sandor Z., Tarnawski A.S., and Szabo S. Cysteamine alters redox state, HIF-1α transcriptional interactions and reduces duodenal mucosal oxygenation: Novel insight into the mechanisms of duodenal ulceration. Biochem. Biophys. Res. Commun. 317 (2004) 121-127
60. Kietzmann T., Jungermann K., and Görlach A. Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases in HepG2 cells. Thromb. Haemost. 89 (2003) 666-674
61. Kietzmann T., Samoylenko A., Roth U., and Jungermann K. Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 101 (2003) 907-914
62. Kietzmann T., Cornesse Y., Brechtel K., Modaressi S., and Jungermann K. Perivenous expression of the mRNA of the three hypoxia-inducible factor alpha-subunits, HIF-1α, HIF-2α and HIF-3α, in rat liver. Biochem. J. 354 (2001) 531-537
63. Kim C.H., Cho Y.S., Chun Y.S., Park J.W., and Kim M.S. Early expression of myocardial HIF-1α in response to mechanical stresses: Regulation by stretch-activated channels and the phosphatidylinositol 3-kinase signaling pathway. Circ. Res. 90 (2002) E25-E33
64. Kim H.H., Lee S.E., Chung W.J., Choi Y., Kwack K., Kim S.W., Kim M.S., Park H., and Lee Z.H. Stabilization of hypoxia-inducible factor-1alpha is involved in the hypoxic stimuli-induced expression of vascular endothelial growth factor in osteoblastic cells. Cytokine 17 (2002) 14-27
65. Kimura C., Oike M., Koyama T., and Ito Y. Impairment of endothelial nitric oxide production by acute glucose overload. Am. J. Physiol. Endocrinol. Metab. 280 (2001) E171-E178
66. Knowles H.J., Raval R.R., Harris A.L., and Ratcliffe P.J. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63 (2003) 1764-1768
67. Kohl R., Zhou J., and Brune B. Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1alpha stabilization. Free Radic. Biol. Med. 40 (2006) 1430-1442
68. Kooy N.W., Royall J.A., Ischiropoulos H., and Beckman J.S. Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radic. Biol. Med. 16 (1994) 149-156
69. Lambeth J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004) 181-189
70. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain: A hypoxic switch. Science 295 (2002) 858-861
71. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
72. LeBel C.P., Ischiropoulos H., and Bondy S.C. Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5 (1992) 227-231
73. Lee E., Yim S., Lee S.K., and Park H. Two transactivation domains of hypoxia-inducible factor-1alpha regulated by the MEK-1/p42/p44 MAPK pathway. Mol. Cells 14 (2002) 9-15
74. Lee C., Kim S.J., Jeong D.G., Lee S.M., and Ryu S.E. Structure of human FIH-1 reveals a unique active site pocket and interaction sites for HIF-1 and VHL. J. Biol. Chem. 278 (2002) 7558-7563
75. Liu C., Shi Y., Han Z., Pan Y., Liu N., Han S., Chen Y., Lan M., Qiao T., and Fan D. Suppression of the dual-specificity phosphatase MKP-1 enhances HIF-1 trans-activation and increases expression of EPO. Biochem. Biophys. Res. Commun. 312 (2003) 780-786
76. Liu L.Z., Hu X.W., Xia C., He J., Zhou Q., Shi X., Fang J., and Jiang B.H. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic. Biol. Med. 41 (2006) 1521-1533
77. Liu Q., Berchner-Pfannschmidt U., Moller U., Brecht M., Wotzlaw C., Acker H., Jungermann K., and Kietzmann T. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. USA 101 (2004) 4302-4307
78. Mahon P.C., Hirota K., and Semenza G.L. FIH-1: A novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15 (2001) 2675-2686
79. Maranchie J.K., and Zhan Y. Nox4 is critical for hypoxia-inducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65 (2005) 9190-9193
80. Marchetti S., Gimond C., Roux D., Gothie E., Pouyssegur J., and Pages G. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice. J. Cell Physiol. 199 (2004) 441-450
81. Masson N., Willam C., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 20 (2001) 5197-5206
82. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
83. Mazure N.M., Chen E.Y., Laderoute K.R., and Giaccia A.J. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90 (1997) 3322-3331
84. McNeill L.A., Hewitson K.S., Claridge T.D., Seibel J.F., Horsfall L.E., and Schofield C.J. Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803. Biochem. J. 367 (2002) 571-575
85. Min J.H., Yang H., Ivan M., Gertler F., Kaelin Jr. W.G., and Pavletich N.P. Structure of an HIF-1α-pVHL complex: Hydroxyproline recognition in signaling. Science 296 (2002) 1886-1889
86. Murrant C.L., and Reid M.B. Detection of reactive oxygen and reactive nitrogen species in skeletal muscle. Microsc. Res. Tech. 55 (2001) 236-248
87. Oehme F., Ellinghaus P., Kolkhof P., Smith T.J., Ramakrishnan S., Hutter J., Schramm M., and Flamme I. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem. Biophys. Res. Commun. 296 (2002) 343-349
88. Ohh M., Park C.W., Ivan M., Hoffman M.A., Kim T.Y., Huang L.E., Pavletich N., Chau V., and Kaelin W.G. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2 (2000) 423-427
89. Page E.L., Robitaille G.A., Pouyssegur J., and Richard D.E. Induction of hypoxia-inducible factor-1alpha by transcriptional and translational mechanisms. J. Biol. Chem. 277 (2002) 48403-48409
90. Park J.H., Kim T.Y., Jong H.S., Kim T.Y., Chun Y.S., Park J.W., Lee C.T., Jung H.C., Kim N.K., and Bang Y.J. Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1alpha in gastric cancer cells. Clin. Cancer Res. 9 (2003) 433-440
91. Pascual O., Denavit-Saubie M., Dumas S., Kietzmann T., Ghilini G., Mallet J., and Pequignot J.M. Selective cardiorespiratory and catecholaminergic areas express the hypoxia-inducible factor-1alpha (HIF-1α) under in vivo hypoxia in rat brainstem. Eur. J. Neurosci. 14 (2001) 1981-1991
92. Pugh C.W., O'Rourke J.F., Nagao M., Gleadle J.M., and Ratcliffe P.J. Activation of hypoxia-inducible factor-1: Definition of regulatory domains within the alpha subunit. J. Biol. Chem. 272 (1997) 11205-11214
93. Qian D., Lin H.Y., Wang H.M., Zhang X., Liu D.L., Li Q.L., and Zhu C. Normoxic induction of the hypoxic-inducible factor-1 alpha by interleukin-1 beta involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol. Reprod. 70 (2004) 1822-1827
94. Richard D.E., Berra E., and Pouyssegur J. Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells. J. Biol. Chem. 275 (2000) 26765-26771
95. Richard D.E., Berra E., Gothie E., Roux D., and Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem. 274 (1999) 32631-32637
96. Robinson K.M., Janes M.S., Pehar M., Monette J.S., Ross M.F., Hagen T.M., Murphy M.P., and Beckman J.S. Selective fluorescent imaging of superoxide in vivo using ethidium-based probes. Proc. Natl. Acad. Sci. USA 103 (2006) 15038-15043
97. Rothe G., and Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J. Leukoc. Biol. 47 (1990) 440-448
98. Salceda S., and Caro J. Hypoxia-inducible factor 1alpha (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272 (1997) 22642-22647
99. Sandau K.B., Zhou J., Kietzmann T., and Brune B. Regulation of the hypoxia-inducible factor 1alpha by the inflammatory mediators nitric oxide and tumor necrosis factor-alpha in contrast to desferroxamine and phenylarsine oxide. J. Biol. Chem. 276 (2001) 39805-39811
100. Schoenfeld A.R., Davidowitz E.J., and Burk R.D. Endoplasmic reticulum/cytosolic localization of von Hippel-Lindau gene products is mediated by a 64-amino acid region. Int. J. Cancer 91 (2001) 457-467
101. Semenza G.L. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 91 (2006) 803-806
102. Semenza G.L., and Wang G.L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12 (1992) 5447-5454
103. Shatrov V.A., Sumbayev V.V., Zhou J., and Brune B. Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1α) accumulation via redox-dependent mechanisms. Blood 101 (2003) 4847-4849
104. Shimmura S., Tsubota K., Oguchi Y., Fukumura D., Suematsu M., and Tsuchiya M. Oxiradical-dependent photoemission induced by a phacoemulsification probe. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2904-2907
105. Sodhi A., Montaner S., Miyazaki H., and Gutkind J.S. MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF. Biochem. Biophys. Res. Commun. 287 (2001) 292-300
106. Sowter H.M., Raval R.R., Moore J.W., Ratcliffe P.J., and Harris A.L. Predominant role of hypoxia-inducible transcription factor (HIF)-1alpha versus HIF-2α in regulation of the transcriptional response to hypoxia. Cancer Res. 63 (2003) 6130-6134
107. Srinivas V., Leshchinsky I., Sang N., King M.P., Minchenko A., and Caro J. Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem. 276 (2001) 21995-21998
108. Stiehl D.P., Jelkmann W., Wenger R.H., and Hellwig-Bürgel T. Normoxic induction of the hypoxia-inducible factor 1alpha by insulin and interleukin-1beta involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512 (2002) 157-162
109. Tacchini L., Dansi P., Matteucci E., and Desiderio M.A. Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22 (2001) 1363-1371
110. Tacchini L., De Ponti C., Matteucci E., Follis R., and Desiderio M.A. Hepatocyte growth factor-activated NF-κB regulates HIF-1 activity and ODC expression, implicated in survival, differently in different carcinoma cell lines. Carcinogenesis 25 (2004) 2089-2100
111. Tanimoto K., Makino Y., Pereira T., and Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19 (2000) 4298-4309
112. Tarpey M.M., Wink D.A., and Grisham M.B. Methods for detection of reactive metabolites of oxygen and nitrogen: In vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R431-R444
113. Thornton R.D., Lane P., Borghaei R.C., Pease E.A., Caro J., and Mochan E. Interleukin 1 induces hypoxia-inducible factor 1 in human gingival and synovial fibroblasts. Biochem. J. 350 (2000) 307-312
114. Tonks N.K. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 121 (2005) 667-670
115. Treins C., Giorgetti-Peraldi S., Murdaca J., Semenza G.L., and Van Obberghen E. Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277 (2002) 27975-27981
116. Wakisaka N., and Pagano J.S. Epstein-Barr virus induces invasion and metastasis factors. Anticancer Res. 23 (2003) 2133-2138
117. Walling C. Fenton's reagent revisited. Acc. Chem. Res. 8 (1975) 125-131
118. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270 (1995) 1230-1237
119. Wang G.L., Jiang B.H., and Semenza G.L. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 212 (1995) 550-556
120. Wang G.L., Jiang B.H., and Semenza G.L. Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216 (1995) 669-675
121. 2 tension. Proc. Natl. Acad. Sci. USA 92 (1995) 5510-5514
122. Wang F.S., Wang C.J., Chen Y.J., Chang P.R., Huang Y.T., Sun Y.C., Huang H.C., Yang Y.J., and Yang K.D. Ras induction of superoxide activates ERK-dependent angiogenic transcription factor HIF-1α and VEGF-A expression in shock wave-stimulated osteoblasts. J. Biol. Chem. 279 (2004) 10331-10337
123. Wellman T.L., Jenkins J., Penar P.L., Tranmer B., Zahr R., and Lounsbury K.M. Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1α (HIF-1α) in explants of human pial arteries. FASEB J. 18 (2004) 379-381
124. Welsh S.J., Bellamy W.T., Briehl M.M., and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62 (2002) 5089-5095
125. 2-regulated gene expression. FASEB J. 16 (2002) 1151-1162
126. Wersto R.P., Rosenthal E.R., Crystal R.G., and Spring K.R. Uptake of fluorescent dyes associated with the functional expression of the cystic fibrosis transmembrane conductance regulator in epithelial cells. Proc. Natl. Acad. Sci. USA 93 (1996) 1167-1172
127. Yu F., White S.B., Zhao Q., and Lee F.S. HIF-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98 (2001) 9630-9635
128. Zelko I.N., and Folz R.J. Extracellular superoxide dismutase functions as a major repressor of hypoxia-induced erythropoietin gene expression. Endocrinology 146 (2005) 332-340
129. Zelzer E., Levy Y., Kahana C., Shilo B.Z., Rubinstein M., and Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1α/ARNT. EMBO J. 17 (1998) 5085-5094
130. Zhao H., Kalivendi S., Zhang H., Joseph J., Nithipatikom K., Vasquez-Vivar J., and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: Potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 34 (2003) 1359-1368
131. Zhao H., Joseph J., Fales H.M., Sokoloski E.A., Levine R.L., Vasquez-Vivar J., and Kalyanaraman B. Detection and characterization of the product of hydroethidine and intracellular superoxide by HPLC and limitations of fluorescence. Proc. Natl. Acad. Sci. USA 102 (2005) 5727-5732
132. Zhou J., Callapina M., Goodall G.J., and Brune B. Functional integrity of nuclear factor kappa B, phosphatidylinositol 3′-kinase, and mitogen-activated protein kinase signaling allows tumor necrosis factor alpha-evoked Bcl-2 expression to provoke internal ribosome entry site-dependent translation of hypoxia-inducible factor 1alpha. Cancer Res. 64 (2004) 9041-9048
133. Zhu X.Y., Rodriguez-Porcel M., Bentley M.D., Chade A.R., Sica V., Napoli C., Caplice N., Ritman E.L., Lerman A., and Lerman L.O. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109 (2004) 2109-2115